OTCM
PAIYY
Market cap7mUSD
May 01, Last price
0.24USD
Name
Aesthetic Medical International Holdings Group Ltd
Chart & Performance
P/E
—
P/S
0.22
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-5.23%
Rev. gr., 5y
-2.16%
Revenues
683m
+1.86%
Net income
-37m
L-50.82%
CFO
74m
P
Profile
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 682,587 1.86% | 670,091 3.79% | ||||||
Cost of revenue | 731,399 | 691,358 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (48,812) | (21,267) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | (15,136) | (18,067) | ||||||
Tax Rate | ||||||||
NOPAT | (33,676) | (3,200) | ||||||
Net income | (37,432) -50.82% | (76,106) -88.63% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 170,001 | 94,153 | ||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 128,904 | 264,683 | ||||||
Long-term debt | 235,347 | 255,070 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | 301,915 | 506,432 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 74,286 | (75,126) | ||||||
CAPEX | (55,244) | (1,678) | ||||||
Cash from investing activities | (52,246) | 3,111 | ||||||
Cash from financing activities | 29,062 | 45,552 | ||||||
FCF | (91,431) | 19,885 | ||||||
| Balance | ||||||||
Cash | 62,336 | 12,161 | ||||||
Long term investments | 1,160 | |||||||
Excess cash | 28,207 | |||||||
Stockholders' equity | 35,652 | (123,857) | ||||||
Invested Capital | 249,972 | 373,961 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 27,304 | |||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 17,085 | 40,219 | ||||||
EV/EBITDA | ||||||||
Interest | 14,474 | 21,635 | ||||||
Interest/NOPBT | ||||||||